Three doses of the commercially available hepatitis B vaccine were administered to each of 43 anti-hepatitis B surface antigen antibody-negative children (including 32 hemophiliacs) who were regularly receiving blood product transfusions. Forty-two (98%) of them had demonstrable anti-hepatitis B surface antigen antibody in their serum, indicating that this group of patients responds favorably to the vaccine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00006454-198601000-00013 | DOI Listing |
Publication Analysis
Top Keywords
hepatitis vaccine
8
anti-hepatitis surface
8
surface antigen
8
serologic response
4
response hepatitis
4
vaccine children
4
children receiving
4
receiving multiple
4
multiple blood
4
blood transfusions
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!